close
Add to watchlist
Charles River Laboratories International Inc (CRL) Services, Business Services
Charles River Laboratories International, Inc. provides research models and laboratory animal support expertise to help its global partners advance their research and drug development efforts. The company offers a portfolio of services to support discovery and imaging, preclinical and early-phase clinical studies, and biopharmaceutical and endotoxin products and services for manufacturing and quality control. Its portfolio spans the entire research and drug development process, from IND consultation to discovery through market approval, allowing customized approaches to support both single-study or broad-based programs. Charles River Laboratories International serves pharmaceutical and biotechnology companies, as well as government agencies, hospitals, and academic institutions. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.
(login to add this stock to your watchlist or favorites)
Key Statistics
| Closing Price | 36.68 |
| Volume | 663775 |
| Volume Avg | 598877 |
| 52 Week High | 42.84 |
| 52 Week Low | 25.52 |
| PE | 17.35 |
| PE (group average) | 40 |
| EPS Year | 2.13 |
| EPS change Q/Q | -1000% |
| EPS change Q/Q Yr ago | 114.81% |
| EPS change Q/Q next Q est | -15.94% |
| EPS change Y/Y | -1000% |
| REV change Q/Q | 1.46% |
| REV change Q/Q Yr ago | -2.22% |
| EPS next Q est | 0.69 |
| EPS next Y est | 2.96 |
| Divident Annual | 0.00 |
| Dividend Yield | 0% |